Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


In this issue


Spoon full of Vitamin D supplements

How to reduce the risks associated with vitamin D self-supplementationSubscription


As the prevalence of vitamin D deficiency rises, the popularity of self-medicating with vitamin D supplements is growing. However, there is potential for overdosing and harm.


Identifying patients at high risk of having a fallSubscription

By ,

People aged 65 years and over have the highest risk of falling, with 30% of people aged over 65 years and 50% of people aged over 80 years falling at least once a year. Falls and fall-related injuries are a common and serious problem for older people. Falling has an impact not only on quality of life and health, but also healthcare costs. The costs to the NHS are estimated at more than £2.3bn per year.

Providing HIV care in community pharmacySubscription

By Kirsteen Hill

HIV is a long-term, chronic condition which is usually only managed by clinical teams in secondary care and antiretroviral (ARV) treatment is usually supplied by hospital pharmacies or homecare companies.

Pharmacy must grasp new clinical opportunities with both handsSubscription


As a GP with 25 years’ experience, a strong interest in medical education, and married to a community pharmacist, I am constantly amazed by how pharmacy has allowed itself to be sidelined and passed over by other medical-related professions. Salaries have not kept pace with similar groups, and there has been little in the way of role development and extension of skills. What few initiatives there are, such as minor ailment schemes, have been piecemeal and under-resourced.

CPD article

Computer illustration of a low-density lipoprotein (LDL) molecule (round) bound to an LDL receptor (LDLR) protein, with a molecule of the enzyme proprotein convertase subtilisin/kexin type 9 (PCSK9, blue) bound to a PCSK9 inhibitor antibody (orange)

Non-statin drugs for the management of dyslipidaemia in adultsSubscription


The role of non-statin drugs, including ezetimibe, fibrates, bile acid binders, nicotinic acid derivatives, omega-3 fatty acid supplements and PCSK9 inhibitors, for the management of dyslipidaemia in adults.


Statin myopathy stain showing muscle fibres in varying stages of necrosis, phagocytes and regeneration

Statins: general safety profile and association with myopathySubscription

By ,

Statin therapy has demonstrated remarkable efficacy in reducing mortalities associated with cardiovascular diseases through preventing myocardial infarction and ischaemic stroke. Despite the proven benefits of statins in this context, there are growing concerns among patients and physicians on the safety of short-term and long-term use and their adverse effects, especially muscle toxicity, resulting in non-adherence and withdrawal of the treatment. Reports and publications ...

Hospital staff at Airedale NHS Foundation Trust use the new electronic prescribing system on the drugs round

Impact of electronic prescribing on patient safety in hospitals: implications for the UKSubscription

By , , , ,

NHS hospitals in England are expected to be paperless by 2020, as set out in a comprehensive framework published by the National Information Board. The use of hospital electronic prescribing (EP) systems is therefore likely to increase rapidly in the near future. The aim of this review is to summarise the available evidence of the impact of inpatient EP on patient safety, with a focus on implications for the UK. MEDLINE and EMBASE were searched to identify systematic and narrative ...

Clinical Pharmacist

CP May 2016, Vol 8, No 5

Cover Story:

Hospital e-prescribing and its impact on patient safety

Read more…

Clinical Pharmacist

View previous issue

Clinical Pharmacist is a monthly, peer-reviewed journal that provides authoritative resources on the clinical management of disease in relation to medicines and up-to-date information about advances in pharmacy and drug development. Clinical Pharmacist publishes Review articles, Perspectives, evidence-based CPD articles and Practice Reports on topics from drug discovery to clinical pharmacology and pharmacy.

The international audience of Pharmaceutical Journal Publications consists of pharmacists, pharmaceutical scientists and healthcare professionals. The journal is available to 44,000 members of the Royal Pharmaceutical Society, as well as non-member individual subscribers and subscribing institutions.